•2026•35 Episodes•1M+
Lakshya’s story centers on a healer and pharma leader whose blood, labor, and signature are repeatedly treated as assets other people can claim. He first appears as the face of a herbal cure for blood freezing, but Maanya’s relapse quickly turns the medical promise into a private crisis. Their relationship is marked by years of blood-based treatment, yet the digests suggest that what looked like devotion may also have involved coercion and missing consent. At the same time, Lakshya is bound by multiple contracts and debts, including service obligations tied to people who once saved him or asked him to repay a favor through Aarogyashala. Maanya, as heiress and company leader, repeatedly tries to control both Lakshya and the family business, even as rumors and public speculation suggest she depends on his blood for survival. Public humiliation becomes a recurring weapon, from forced summons and contract stripping to staged demonstrations that prove healing blood can work while visibly draining the donor. As Lakshya resists being treated like a subordinate, the conflict widens from personal grievance into a struggle over ownership, medical access, and corporate authority. Aarogyashala becomes a crucial battleground because its healer rejects money and fame, forcing the characters to confront limits they cannot buy through influence. Maanya’s condition worsens into a rare aging syndrome, and she is repeatedly pushed toward desperate bargaining for a cure. Lakshya eventually declares his contractual service over and refuses to keep helping her, which shifts him from exploited insider to open rival. That break triggers financial fallout for the Jain Group, with shares falling, contracts canceled, and partners withdrawing as scandals spread. The company’s attempt to defend its new drug also collapses into public controversy when Lakshya accuses it of modifying his original Bio Capsule into something dangerous. A live comparison of rival medicines on isolated patients deepens the scandal and makes the stakes feel national rather than merely familial. In the middle of that collapse, Mr. Jain tries to buy Lakshya back with ownership and control, but Lakshya refuses to return. Maanya’s desperation then turns personal again when she confronts Lakshya for not curing her, only to learn he had already used his blood to save others and that her own final dose was wasted on a dog. Jay’s opportunism is exposed as well, leaving Maanya with fewer allies as her power erodes. The batch summaries end with Maanya reported to have died by suicide, while Lakshya remains defined by the cost of being indispensable to everyone else.
Lakshya’s story centers on a healer and pharma leader whose blood, labor, and signature are repeatedly treated as assets other people can claim. He first appears as the face of a herbal cure for blood freezing, but Maanya’s relapse quickly turns the medical promise into a private crisis. Their relationship is marked by years of blood-based treatment, yet the digests suggest that what looked like devotion may also have involved coercion and missing consent. At the same time, Lakshya is bound by multiple contracts and debts, including service obligations tied to people who once saved him or asked him to repay a favor through Aarogyashala. Maanya, as heiress and company leader, repeatedly tries to control both Lakshya and the family business, even as rumors and public speculation suggest she depends on his blood for survival. Public humiliation becomes a recurring weapon, from forced summons and contract stripping to staged demonstrations that prove healing blood can work while visibly draining the donor. As Lakshya resists being treated like a subordinate, the conflict widens from personal grievance into a struggle over ownership, medical access, and corporate authority. Aarogyashala becomes a crucial battleground because its healer rejects money and fame, forcing the characters to confront limits they cannot buy through influence. Maanya’s condition worsens into a rare aging syndrome, and she is repeatedly pushed toward desperate bargaining for a cure. Lakshya eventually declares his contractual service over and refuses to keep helping her, which shifts him from exploited insider to open rival. That break triggers financial fallout for the Jain Group, with shares falling, contracts canceled, and partners withdrawing as scandals spread. The company’s attempt to defend its new drug also collapses into public controversy when Lakshya accuses it of modifying his original Bio Capsule into something dangerous. A live comparison of rival medicines on isolated patients deepens the scandal and makes the stakes feel national rather than merely familial. In the middle of that collapse, Mr. Jain tries to buy Lakshya back with ownership and control, but Lakshya refuses to return. Maanya’s desperation then turns personal again when she confronts Lakshya for not curing her, only to learn he had already used his blood to save others and that her own final dose was wasted on a dog. Jay’s opportunism is exposed as well, leaving Maanya with fewer allies as her power erodes. The batch summaries end with Maanya reported to have died by suicide, while Lakshya remains defined by the cost of being indispensable to everyone else.
The Price Of A Miracle is a Politics Series in Hindi, streaming on Kuku TV.
The Price Of A Miracle has 35 episodes, watched over 1M+ times on Kuku TV.
The Price Of A Miracle is available to watch in Hindi on Kuku TV.
The Price Of A Miracle was released in 2026 and is streaming on Kuku TV.
The Price Of A Miracle is rated A.
The cast of The Price Of A Miracle includes Hridyanshi Toor, Mashuk Hasmi, Taramani Production, and Om Shiva.
You can watch The Price Of A Miracle online on Kuku TV or download the Kuku TV app to start playing. Open any episode above to start watching instantly.
